A Troubling Lab Report 6-4-07 Portfolio - Stockpickr! Your Source for Stock Ideas

A Troubling Lab Report 6-4-07

4714 views

TheStreet.com Rating: B

Rate Now:

average rating: 0.00 / 0 ratings

printer friendly

send to a friend

Created by Barrons

DESCRIPTION:

Date updated:06-02-2007

FANS OF ABBOTT LABORATORIES ARE FOCUSED on the company's launch of a new drug-coated cardiac stent, which they believe could trump competitors' products and snare up to 40% of the $5 billion market. Expectations for the product have helped fuel a 50% increase in the past 18 months in shares of the Abbott Park, Ill.-based health-care concern, which closed Friday at 56.30.

But investors may be overlooking the fact that most of Abbott's profits come from its slower-growth, lower-multiple pharmaceutical division, not jazzy technologies. And some prominent doctors have started questioning the safety and efficacy of one of Abbott's best-selling drugs, TriCor, which helps patients lower triglycerides, a type of non-cholesterol fat.

GSK
Glaxosmithkline P
$33.96
0.00%
$33.64

Concerns about fenofibrate center on creatinine, a substance produced by the muscles and eliminated by the kidneys. A rise in creatinine typically indicates some sort of kidney malfunction. Fenofibrates and other fibrate drugs have been known to result in elevated creatinine levels. A study published in March in the Journal of the American Medical Association by Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic, showed that 19 patients, or 38% in a control group that took fenofibrate, saw their creatinine levels rise above what is considered the upper limits of normal

People owning GSK also tend to own: ABT DGX EPD FMD JNJ JOSB JTX

TheStreet.com Rating: C What is this?

MRK
Merck & Co.
$27.70
+0.62%
$27.51

Nissen also raised concerns about Vioxx as well

People owning MRK also tend to own: ACAS CLP HPQ PHI SHFL VZ BR

TheStreet.com Rating: C+ What is this?

ABI
Safety First Trus
$9.8178
0.00%
$9.41

Barrons feels that the stock is pricey at 56- especially as questions about TriCor seem destined to grow

People owning ABI also tend to own: FXE FACT ADP CX INTC LUK BAC

TheStreet.com Rating: A+ What is this?

AMGN
Amgen Inc.
$50.73
+1.26%
$50.40

No Analysis added

People owning AMGN also tend to own: AAPL GE SGP CECE MRVL OMRI ANF

TheStreet.com Rating: B What is this?

DNA
N/a
$80.43
0.00
$80.43

No Analysis added

People owning DNA also tend to own: ABT AMGN BDX BMY CAH FRX GENZ

TheStreet.com Rating: B What is this?

ABT
Abbott Laboratori
$45.15
0.00%
$44.82

No Analysis added

People owning ABT also tend to own: AGN BMY BRL CEPH ENDP FRX HSP

TheStreet.com Rating: B What is this?

A Troubling Lab Report 6-4-07's Blog
No Blogs Found

Comments not available

Top Do-It-Yourself Portfolios
» agtest1
» Joy
» tsamanuli Portfolio 1
» brueckenc Portfolio 1
» HMH1
show all

Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:47 p.m. EDT on July 6, 2009 Oil was in the red on Monday, sending stocks and the three major indices lower as well. Bank of America (...

07.06.09 | 12:48 PM

Top Tech Short-Squeeze Plays

By Fred Fuld Posted at 12:11 p.m. EDT on July 6, 2009 Revenue and earnings surprises can cause stocks to make sharp moves upwards, which in turn can set off a short sq...

07.06.09 | 12:11 PM

Rocket Stocks for the Week

By Jonas Elmerraji Posted at 11:07 a.m. EDT on July 6, 2009 As we approach the second week in July, the markets have done a good job of matching the summer heat by keep...

07.06.09 | 11:08 AM

Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM

Nymph's Trading Daily Trading Diary

04.13.09 | 01:10 AM From author Trading Nymph

General market Technical Analysi...

11.14.07 | 22:55 PM From author ZA

The Presidential/Political Thread

01.02.08 | 08:05 AM From author Dave Cox

Will black social ills take a ba...

11.22.08 | 18:53 PM From author Valerie Vecchio

more forums